🇺🇸 FDA
Patent

US 10456392

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

granted A61KA61K31/4745A61K31/497

Quick answer

US patent 10456392 (Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/4745, A61K31/497, A61K31/506, A61K31/5377